Literature DB >> 19038254

Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke.

Nils Henninger1, James Bouley, Bernt T Bråtane, Birgül Bastan, Meghan Shea, Marc Fisher.   

Abstract

BACKGROUND AND
PURPOSE: Laser Doppler flowmetry (LDF) is increasingly used to assess adequate occlusion after embolic stroke (ES) in rats.
METHODS: Employing LDF, relative regional cerebral blood flow (rCBF) was continuously monitored during the first 2 h following ES and correlated with 24 h 2,3,5-triphenyltetrazolium chloride (TTC)-staining of corrected infarct volume. In a preliminary experiment (n=18), it was demonstrated that rCBF-reduction to 37% or less of baseline correctly identified occlusion success in the suture middle cerebral artery occlusion (sMCAO) model. Using the same methodology, we then assessed whether LDF allowed for identification of animals with successful ES (experiment 2, n=26) and tissue plasminogen activator (tPA)-mediated reperfusion following ES (experiment 3, n=28).
RESULTS: In ES rats, 3 infarct patterns were identified: small (<150 mm(3)), medium ( approximately 250 mm(3)), and large (>400 mm(3)). Rats with an rCBF below 45% of preocclusion values had an 80% probability of developing medium to large infarcts, whereas rats with an rCBF above the 45%-threshold had a 100% chance of developing small infarcts. LDF did not reliably detect reperfusion in tPA-treated animals (sensitivity=40%), because it apparently occurred within brain areas remote from the LDF-monitoring site as indicated by TTC-staining and magnetic resonance angiography in a subset of animals.
CONCLUSION: LDF is an excellent screening method to identify animals with successful ES; however, distinction of medium from large infarcts is not possible, the critical threshold for identifying adequate occlusion is higher than in the sMCAO model, and LDF poorly predicts tPA-mediated reperfusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038254     DOI: 10.1016/j.expneurol.2008.10.013

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

1.  Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1.

Authors:  Nils Henninger; James Bouley; Elif M Sikoglu; Jiyan An; Constance M Moore; Jean A King; Robert Bowser; Marc R Freeman; Robert H Brown
Journal:  Brain       Date:  2016-02-11       Impact factor: 13.501

2.  A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes.

Authors:  Xiang Fan; Jianhua Qiu; Zhanyang Yu; Haibin Dai; Aneesh B Singhal; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2011-11-03       Impact factor: 7.914

3.  Visualization of clot lysis in a rat embolic stroke model: application to comparative lytic efficacy.

Authors:  Ronn P Walvick; Bernt T Bråtane; Nils Henninger; Kenneth M Sicard; James Bouley; Zhanyang Yu; Eng Lo; Xiaoying Wang; Marc Fisher
Journal:  Stroke       Date:  2011-03-03       Impact factor: 7.914

4.  Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.

Authors:  Xiang Fan; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2013-02-19       Impact factor: 7.914

5.  Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI.

Authors:  Elisa Cuccione; Alessandro Versace; Tae-Hee Cho; Davide Carone; Lise-Prune Berner; Elodie Ong; David Rousseau; Ruiyao Cai; Laura Monza; Carlo Ferrarese; Erik P Sganzerla; Yves Berthezène; Norbert Nighoghossian; Marlène Wiart; Simone Beretta; Fabien Chauveau
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Clot injection technique affects thrombolytic efficacy in a rat embolic stroke model: implications for translaboratory collaborations.

Authors:  Marilena Marinescu; James Bouley; Juyu Chueh; Marc Fisher; Nils Henninger
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-15       Impact factor: 6.200

7.  Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.

Authors:  Haihao Zhu; Xiang Fan; Zhanyang Yu; Jianxiang Liu; Yoshihiro Murata; Jie Lu; Song Zhao; Katherine A Hajjar; Eng H Lo; Xiaoying Wang
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

8.  Early insulin glycemic control combined with tPA thrombolysis reduces acute brain tissue damages in a focal embolic stroke model of diabetic rats.

Authors:  Xiang Fan; Mingming Ning; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2012-11-01       Impact factor: 7.914

9.  Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats.

Authors:  Rong Jin; Xiaolei Zhu; Guohong Li
Journal:  J Vis Exp       Date:  2014-09-17       Impact factor: 1.355

10.  Mutant prourokinase with adjunctive C1-inhibitor is an effective and safer alternative to tPA in rat stroke.

Authors:  Simone Tomasi; Paolo Sarmientos; Giada Giorda; Victor Gurewich; Alessandro Vercelli
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.